PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 272 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $652,686 | -61.2% | 78,166 | -38.2% | 0.00% | – |
| Q2 2023 | $1,682,437 | +102.1% | 126,499 | +76.0% | 0.00% | – |
| Q1 2023 | $832,347 | +177.5% | 71,878 | +96.0% | 0.00% | – |
| Q4 2022 | $299,928 | +60.4% | 36,666 | +14.2% | 0.00% | – |
| Q3 2022 | $187,000 | +52.0% | 32,112 | +15.4% | 0.00% | – |
| Q2 2022 | $123,000 | -88.5% | 27,823 | -76.3% | 0.00% | – |
| Q1 2022 | $1,069,000 | -75.8% | 117,488 | -45.6% | 0.00% | -100.0% |
| Q4 2021 | $4,418,000 | -12.7% | 215,939 | +9.0% | 0.00% | 0.0% |
| Q3 2021 | $5,063,000 | -39.1% | 198,174 | -16.6% | 0.00% | -50.0% |
| Q2 2021 | $8,307,000 | +31.4% | 237,563 | +25.2% | 0.00% | +100.0% |
| Q1 2021 | $6,322,000 | -25.9% | 189,774 | -42.3% | 0.00% | -50.0% |
| Q4 2020 | $8,536,000 | +524.9% | 329,026 | +137.8% | 0.00% | – |
| Q3 2020 | $1,366,000 | +222.9% | 138,375 | +12.4% | 0.00% | – |
| Q2 2020 | $423,000 | +46.9% | 123,061 | +30.8% | 0.00% | – |
| Q1 2020 | $288,000 | -83.6% | 94,090 | -72.4% | 0.00% | – |
| Q4 2019 | $1,751,000 | +35.4% | 340,545 | +35.9% | 0.00% | – |
| Q3 2019 | $1,293,000 | -14.7% | 250,611 | -0.0% | 0.00% | – |
| Q2 2019 | $1,516,000 | +131.5% | 250,659 | +176.7% | 0.00% | – |
| Q1 2019 | $655,000 | +5.8% | 90,603 | +8.3% | 0.00% | – |
| Q4 2018 | $619,000 | +64.2% | 83,656 | +19.9% | 0.00% | – |
| Q3 2018 | $377,000 | +53.3% | 69,792 | +1.0% | 0.00% | – |
| Q2 2018 | $246,000 | +68.5% | 69,124 | -2.8% | 0.00% | – |
| Q1 2018 | $146,000 | -61.0% | 71,140 | -49.8% | 0.00% | – |
| Q4 2017 | $374,000 | -52.1% | 141,711 | -4.6% | 0.00% | – |
| Q3 2017 | $781,000 | +50.2% | 148,531 | +1.6% | 0.00% | – |
| Q2 2017 | $520,000 | -54.4% | 146,234 | -33.7% | 0.00% | – |
| Q1 2017 | $1,140,000 | +125.3% | 220,446 | +65.6% | 0.00% | – |
| Q4 2016 | $506,000 | +54.3% | 133,138 | +264.2% | 0.00% | – |
| Q3 2016 | $328,000 | -95.0% | 36,561 | -96.1% | 0.00% | -100.0% |
| Q2 2016 | $6,532,000 | +1481.6% | 928,498 | +1811.3% | 0.00% | – |
| Q1 2016 | $413,000 | -27.8% | 48,579 | +11.6% | 0.00% | – |
| Q4 2015 | $572,000 | +25.4% | 43,525 | -65.1% | 0.00% | – |
| Q3 2015 | $456,000 | +330.2% | 124,634 | +575.3% | 0.00% | – |
| Q2 2015 | $106,000 | -61.9% | 18,455 | -61.4% | 0.00% | – |
| Q1 2015 | $278,000 | +105.9% | 47,838 | +177.2% | 0.00% | – |
| Q4 2014 | $135,000 | +938.5% | 17,256 | +552.4% | 0.00% | – |
| Q3 2014 | $13,000 | -48.0% | 2,645 | -35.4% | 0.00% | – |
| Q2 2014 | $25,000 | +525.0% | 4,092 | +445.6% | 0.00% | – |
| Q4 2013 | $4,000 | – | 750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |